Search

everythinglearnresearchcommunity

for

Search:↓

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Pranlukast and mirabegron may work as new diabetes drugs.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

RU 58841 may treat acne, hair loss, and excessive hair growth.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

GFRα2 is essential for controlling neuron size but not for target innervation in certain sensory neurons.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

TRPV4 slows hair growth by affecting hair follicle cells.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

New hybrid compound found to effectively prevent hair loss.